Adequate exposure to tacrolimus with sublingual administration in pediatric liver transplant patients

被引：3
|
作者：
Riva, Natalia [1 ]
Galvan, Maria E. [2 ]
Caceres-Guido, Paulo [1 ]
Dip, Marcelo [3 ]
Licciardone, Nieves [4 ]
Imventarza, Oscar [3 ]
Schaiquevich, Paula [1 ]
Buamscha, Daniel [2 ]
机构：
[1] Hosp Pediat JP Garrahan, Unit Clin Pharmacokinet, Buenos Aires, DF, Argentina
[2] Hosp Pediat JP Garrahan, Intens Care Unit, Buenos Aires, DF, Argentina
[3] Hosp Pediat JP Garrahan, Liver Transplantat, Buenos Aires, DF, Argentina
[4] Hosp Pediat JP Garrahan, Lab, Buenos Aires, DF, Argentina
来源：
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS | 2017年 / 55卷 / 04期
关键词：
KIDNEY;
D O I：
10.5414/CP202719
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：352 / 354
页数：3
相关论文
共 50 条
  • [31] Pediatric liver transplant recipient factors that influence tacrolimus absorption
    Chandran, Mary
    Yoeli, Dor
    Sater, Anna
    Karrer, Fritz
    Adams, Megan
    PEDIATRIC TRANSPLANTATION, 2022, 26
  • [32] Pediatric Liver Transplant Factors That Influence Tacrolimus Absorption.
    Chandran, M.
    Yoeli, D.
    Sater, A.
    Karrer, F.
    Adams, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 980 - 980
  • [33] Gout in liver transplant patients receiving tacrolimus
    Gerster, JC
    Dudler, M
    Halkic, N
    Gillet, M
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (07) : 894 - 895
  • [34] Pharmacodynamic study of tacrolimus in liver transplant patients
    Daldoul, M.
    Charfi, R.
    Ben Sassi, M.
    Ben Belgacem, M.
    Ben Hammamia, S.
    Gaies, E.
    Trabelsi, S.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2023, 37 : 199 - 199
  • [35] Determining the conversion ratios for oral versus sublingual administration of tacrolimus in solid organ transplant recipients
    Al Sagheer, Tiba
    Enderby, Cher Y.
    CLINICAL TRANSPLANTATION, 2019, 33 (10)
  • [36] The potential impact of hematocrit correction on evaluation of tacrolimus target exposure in pediatric kidney transplant patients
    Anne M. Schijvens
    Fransje H. S. van Hesteren
    Elisabeth A. M. Cornelissen
    Charlotte M. H. H. T. Bootsma-Robroeks
    Roger J. M. Brüggemann
    David M. Burger
    Saskia N. de Wildt
    Michiel F. Schreuder
    Rob ter Heine
    Pediatric Nephrology, 2019, 34 : 507 - 515
  • [37] The potential impact of hematocrit correction on evaluation of tacrolimus target exposure in pediatric kidney transplant patients
    Schijvens, Anne M.
    van Hesteren, Fransje H. S.
    Cornelissen, Elisabeth A. M.
    Bootsma-Robroeks, Charlotte M. H. H. T.
    Bruggemann, Roger J. M.
    Burger, David M.
    de Wildt, Saskia N.
    Schreuder, Michiel F.
    ter Heine, Rob
    PEDIATRIC NEPHROLOGY, 2019, 34 (03) : 507 - 515
  • [38] Sublingual Tacrolimus as an Alternative to Intravenous Route in Patients With Thoracic Transplant: A Retrospective Study
    Collin, C.
    Boussaud, V.
    Lefeuvre, S.
    Amrein, C.
    Glouzman, A. S.
    Havard, L.
    Billaud, E. M.
    Guillemain, R.
    TRANSPLANTATION PROCEEDINGS, 2010, 42 (10) : 4331 - 4337
  • [39] Administration of tacrolimus in 50 liver transplantation patients
    Manal Abdel Ruzig
    Hepatobiliary & Pancreatic Diseases International, 2002, (04) : 492 - 494
  • [40] Sublingual administration of tacrolimus is a feasible route and requires a lower dose to achieve similar drug exposition in adult liver transplant recipients.
    Solari, Sandra
    Cancino, Alejandra
    Norero, Blanca M.
    Wolff, Rodrigo
    Barrera, Francisco
    Soza, Alejandro
    Arrese, Marco
    Francisco Guerra, Juan
    Jarufe, Nicolas
    Martinez, Jorge A.
    Benitez, Carlos E.
    HEPATOLOGY, 2015, 62 : 812A - 812A
12345